<?xml version="1.0" encoding="UTF-8"?>
<p id="Par44">Amongst the seven antiviral drugs, Ritonavir showed the highest binding energy (-7.45 kcal/mol) and lowest inhibitory constant K
 <italic>i</italic> value (3.49 µM). Ritonavir produced hydrogen bond interactions with Thr26, His41 and Cys145 SARS-CoV-2 amino acids (Fig. 
 <xref rid="Fig7" ref-type="fig">7</xref>c). A combination of two HIV-1 protease inhibitors, lopinavir and ritonavir, were given to critically ill SARS-CoV 2 infected patients [
 <xref ref-type="bibr" rid="CR48">48</xref>]. However, the combination therapy of lopinavir and ritonavir was also stopped early in 13 patients (total recruitment 99 patients) due to associated gastrointestinal adverse events [
 <xref ref-type="bibr" rid="CR48">48</xref>].
</p>
